Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample	TREATMENT
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.5209	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.5209	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.5919	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.6547	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.7616	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.8061	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.8188	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.8764	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.1236	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.2089	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.2264	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.3515	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.3653	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.7241	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	2.0362	Peak area	Plasma	Saline